Precigen Inc. is a biopharmaceutical company. It specialise in the development of gene and cell therapies for immuno-oncology, autoimmune disorders and infectious diseases. The company's transformative therapeutic platforms, including UltraCAR-T(TM), AdenoVerse(TM) cytokine therapies, multifunctional therapeutics and off-the-shelf AdenoVerse(TM) immunotherapies, as well as ActoBio Therapeutics, Exemplar Genetics and Triple-Gene from our subsidiaries. Precigen Inc., formerly known as Intrexon Corporation, is based in Germantown, Maryland.
Revenue (Most Recent Fiscal Year) | $6.22M |
Net Income (Most Recent Fiscal Year) | $-95.90M |
PE Ratio (Current Year Earnings Estimate) | -- |
PE Ratio (Trailing 12 Months) | -- |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | 56.78 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 2.98 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
Pre-Tax Margin (Trailing 12 Months) | -1547.98% |
Net Margin (Trailing 12 Months) | -1540.63% |
Return on Equity (Trailing 12 Months) | -55.47% |
Return on Assets (Trailing 12 Months) | -43.25% |
Current Ratio (Most Recent Fiscal Quarter) | 2.99 |
Quick Ratio (Most Recent Fiscal Quarter) | 2.99 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
Inventory Turnover (Trailing 12 Months) | -- |
Book Value per Share (Most Recent Fiscal Quarter) | $0.48 |
Earnings per Share (Most Recent Fiscal Quarter) | $-0.09 |
Earnings per Share (Most Recent Fiscal Year) | $-0.35 |
Diluted Earnings per Share (Trailing 12 Months) | $-0.39 |
Exchange | NASDAQ |
Sector | Healthcare |
Industry | Biotechnology |
Common Shares Outstanding | 248.92M |
Free Float | 145.12M |
Market Capitalization | $353.46M |
Average Volume (Last 20 Days) | 0.73M |
Beta (Past 60 Months) | 1.73 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 41.70% |
Percentage Held By Institutions (Latest 13F Reports) | 33.51% |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |